Vossebeld P - Search Results

1

Dose-finding study of valspodar (PSC 833) with daunorubicin and cytarabine to reverse multidrug resistance in elderly patients with previously untreated acute myeloid leukemia.

Sonneveld P, Burnett A, Vossebeld P, Ben-Am M, Rosenkranz G, Pfister C, Verhoef G, Dekker A, Ossenkoppele G, Ferrant C, Yin L, Gratwohl A, Kovacsovics T, Vellenga E, Capdeville R, Löwenberg B. Sonneveld P, et al. Among authors: vossebeld p. Hematol J. 2000;1(6):411-21. doi: 10.1038/sj.thj.6200050. Hematol J. 2000. PMID: 11920222 Clinical Trial.

2

Reversal of multidrug resistance in hematological malignancies.

Vossebeld PJ, Sonneveld P. Vossebeld PJ, et al. Blood Rev. 1999 Jun;13(2):67-78. doi: 10.1016/s0268-960x(99)90013-9. Blood Rev. 1999. PMID: 10414943 Review. No abstract available.

3

Drug resistance in multiple myeloma.

Sonneveld P, Lokhorst HM, Vossebeld P. Sonneveld P, et al. Among authors: vossebeld p. Semin Hematol. 1997 Oct;34(4 Suppl 5):34-9. Semin Hematol. 1997. PMID: 9408959 Review.

4

ABCB1 gene polymorphisms are not associated with treatment outcome in elderly acute myeloid leukemia patients.

van der Holt B, Van den Heuvel-Eibrink MM, Van Schaik RH, van der Heiden IP, Wiemer EA, Vossebeld PJ, Löwenberg B, Sonneveld P. van der Holt B, et al. Among authors: vossebeld pj. Clin Pharmacol Ther. 2006 Nov;80(5):427-39. doi: 10.1016/j.clpt.2006.07.005. Clin Pharmacol Ther. 2006. PMID: 17112800

5

Increased expression of the breast cancer resistance protein (BCRP) in relapsed or refractory acute myeloid leukemia (AML).

van den Heuvel-Eibrink MM, Wiemer EA, Prins A, Meijerink JP, Vossebeld PJ, van der Holt B, Pieters R, Sonneveld P. van den Heuvel-Eibrink MM, et al. Among authors: vossebeld pj. Leukemia. 2002 May;16(5):833-9. doi: 10.1038/sj.leu.2402496. Leukemia. 2002. PMID: 11986944

6

van den Heuvel-Eibrink MM, Wiemer EA, de Boevere MJ, van der Holt B, Vossebeld PJ, Pieters R, Sonneveld P. van den Heuvel-Eibrink MM, et al. Among authors: vossebeld pj. Blood. 2001 Jun 1;97(11):3605-11. doi: 10.1182/blood.v97.11.3605. Blood. 2001. PMID: 11369657 Free article.

7

Identification of multidrug resistance-associated protein 1 and glutathione as multidrug resistance mechanisms in human prostate cancer cells: chemosensitization with leukotriene D4 antagonists and buthionine sulfoximine.

van Brussel JP, Oomen MA, Vossebeld PJ, Wiemer EA, Sonneveld P, Mickisch GH. van Brussel JP, et al. Among authors: vossebeld pj. BJU Int. 2004 Jun;93(9):1333-8. doi: 10.1111/j.1464-410X.2004.04847.x. BJU Int. 2004. PMID: 15180633

8

Effect of tumor necrosis factor-induced integrin activation on Fc gamma receptor II-mediated signal transduction: relevance for activation of neutrophils by anti-proteinase 3 or anti-myeloperoxidase antibodies.

Reumaux D, Vossebeld PJ, Roos D, Verhoeven AJ. Reumaux D, et al. Among authors: vossebeld pj. Blood. 1995 Oct 15;86(8):3189-95. Blood. 1995. PMID: 7579414 Free article.

9

Heterotypic Fc gamma R clusters evoke a synergistic Ca2+ response in human neutrophils.

Vossebeld PJ, Kessler J, von dem Borne AE, Roos D, Verhoeven AJ. Vossebeld PJ, et al. J Biol Chem. 1995 May 5;270(18):10671-9. doi: 10.1074/jbc.270.18.10671. J Biol Chem. 1995. PMID: 7738004 Free article.

10

The anti-Fc gamma RIII mAb 3G8 induces neutrophil activation via a cooperative actin of Fc gamma RIIIb and Fc gamma RIIa.

Vossebeld PJ, Homburg CH, Roos D, Verhoeven AJ. Vossebeld PJ, et al. Int J Biochem Cell Biol. 1997 Mar;29(3):465-73. doi: 10.1016/s1357-2725(96)00160-4. Int J Biochem Cell Biol. 1997. PMID: 9202425

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

17 results

Search Page